Jefferies & Co. advice for Dermapharm
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| May 21, 2021 | Jefferies & Co. | Dermapharm | Buy | 78.00 EUR | 39.74 % |
Advice details
New York - Op 21 mei (her)starten de analisten van Jefferies & Co. met het volgen van Dermapharm (ISIN: DE000A2GS5D8) met een koopadvies. Het 12-maands koersdoel is vastgesteld op 78.0 EUR
Last Jefferies & Co. advice for Dermapharm
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| May 21, 2021 | Jefferies & Co. | Dermapharm | Buy | 78.00 EUR | 39.74 % |
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 